Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology
- 1 May 2014
- journal article
- review article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 112 (1), 1-8
- https://doi.org/10.1016/j.ymgme.2014.02.011
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 39 references indexed in Scilit:
- Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systemsBioscience Reports, 2013
- Imaging of enzyme replacement therapy using PETProceedings of the National Academy of Sciences of the United States of America, 2010
- Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse ModelPLOS ONE, 2010
- Recommendations on Diagnosis, Treatment, and Monitoring for Gaucher DiseaseThe Journal of Pediatrics, 2009
- Characterization of gene-activated human acid- -glucosidase: Crystal structure, glycan composition, and internalization into macrophagesGlycobiology, 2009
- Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in miceJournal of Lipid Research, 2008
- Is the Drought Over for Pharming?Science, 2008
- Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell systemPlant Biotechnology Journal, 2007
- The Role of Mannosylated Enzyme and the Mannose Receptor in Enzyme Replacement TherapyAmerican Journal of Human Genetics, 2005
- Plant cell cultures for the production of recombinant proteinsNature Biotechnology, 2004